REG - Mountview Estates. - Director/PDMR Shareholding

Mountview Estates P.L.C.Announcement

19/09/2024 18:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240919:nRSS9512Ea&default-theme=true

RNS Number : 9512E  Mountview Estates PLC  19 September 2024

Mountview Estates Plc

Director/PDMR Shareholding

19 September 2024

 

For immediate release

 

 

Mountview Estates Plc

 ("Mountview" or "the Company")

Director/PDMR Shareholding

Mountview Estates Plc (LSE: MTVW) announces that Dr Andrew Williams, a
non-executive director, informed the Company today that his wife, Charlotte
Williams, had sold 3,400 Ordinary Shares in the capital of the Company on 19
September 2024 at a price of £92.50 per share.

 

Following this transaction, Dr Williams' total beneficial interest in the
Company will be 57,806 Ordinary Shares, representing 1.48 per cent. of the
Company's total voting rights.

 

The information contained in this notification is disclosed in accordance with
the requirements of the EU Market Abuse Regulation.

 

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING
MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

 1   Details of the person discharging managerial responsibilities/persons closely
     associated
 a)  Name                                                                        Dr Andrew Raymond Williams, Charlotte Joy Williams and two minor children
 2   Reason for the notification
 a)  Position/status

                                                                                 Non-Executive Director and PCAs

 b)  Initial notification / amendment                                            Initial Notification
 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                                        Mountview Estates Plc
 b)  LEI                                                                         213800CWH9IB4DTEYG96
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument Identification  Ordinary shares of 5 pence each
     code

                                                                                 Identification code GB0006081037

 b)  Nature of the transaction                                                   Sale of Ordinary Shares
 c)  Price(s) and volume(s)

   Price(s)  Volume(s)
                                                                                 Sale  £92.50    3,400

 

 d)  Aggregated information - Aggregated volume and Price

   Price(s)  Volume(s)
                                                                                 Sale  £92.50    3,400
 e)  Date of the transactions                                                    19 September 2024

 f)  Place of the transactions                                                   London Stock Exchange (XLON)

 

 

d)

Aggregated information - Aggregated volume and Price

 

       Price(s)  Volume(s)
 Sale  £92.50    3,400

e)

Date of the transactions

19 September 2024

 

f)

Place of the transactions

London Stock Exchange (XLON)

 

 

Further Information:

 

For further information on the Company,
visit:                  www.mountviewplc.co.uk
(http://www.mountviewplc.co.uk)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHFLFLDAIIALIS